A Massachusetts General Hospital (MGH) research team has identified a surprising new role for the immune cells called macrophages—improving the effectiveness of nanoparticle-delivered cancer therapies. In their Science ...
May 31, 2017
0
37
As the UK government looks for an exit strategy to Britain's COVID-19 lockdown a nanomedicine expert from The University of Manchester believes a care model usually applied to cancer patients could provide a constructive ...
Apr 27, 2020
0
185
Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.
Feb 20, 2024
0
15
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs ...
May 22, 2013
0
0
Bioengineers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed a smart anti-cancer nanoparticle with precisely targeted tumor-killing activity superior to previous technologies.
Apr 5, 2018
0
41
Amyloids, or fibrous aggregates of abnormally folded proteins, are a common feature in degenerative diseases such as Alzheimer's, diabetes and cancer. Amyloids occur naturally in the body, but despite decades of research, ...
Apr 22, 2013
0
1
(Medical Xpress)—Antibodies are of enormous value to society as therapeutic and diagnostic agents. There are many scientists worldwide interested in producing their own novel engineered antibody based molecules as part ...
Jun 5, 2013
0
0
A new method of delivering cancer drugs that could cut down on chemotherapy's side effects and boost the strength of the tumor-fighting medicine has shown promise, US researchers said Wednesday.
Apr 4, 2012
0
0
University of Liverpool's Nanomedicine research has been recognized by The (US) President's Emergency Plan for AIDS Relief and a fundraising campaign to help improve drug therapies for children with HIV has reached its target ...
Jun 3, 2019
0
6
BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called AccurinsTM, announced today the presentation of late-breaker clinical data for BIND-014, ...
Apr 4, 2012
0
0
Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. One nanometer is one-millionth of a millimeter.
Nanomedicine research is receiving funding from the US National Institute of Health. Of note is the funding in 2005 of a five-year plan to set up four nanomedicine centers. In April 2006, the journal Nature Materials estimated that 130 nanotech-based drugs and delivery systems were being developed worldwide.
This text uses material from Wikipedia, licensed under CC BY-SA
